167 related articles for article (PubMed ID: 8731088)
1. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipoprotein(a) on mesangial cell proliferation and viability.
Greiber S; Krämer-Guth A; Pavenstädt H; Gutenkunst M; Schollmeyer P; Wanner C
Nephrol Dial Transplant; 1996 May; 11(5):778-85. PubMed ID: 8671894
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms of lipid injury in the glomerulus.
Schlondorff D
Am J Kidney Dis; 1993 Jul; 22(1):72-82. PubMed ID: 8322798
[TBL] [Abstract][Full Text] [Related]
4. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
Krämer-Guth A; Nauck M; Pavenstädt H; Königer M; Wieland H; Schollmeyer P; Wanner C
J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247
[TBL] [Abstract][Full Text] [Related]
5. VLDL and LDL metabolism in human and rat mesangial cells.
Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Wieland H; Schollmeyer P; Wanner C
Nephron; 1996; 74(2):378-85. PubMed ID: 8893159
[TBL] [Abstract][Full Text] [Related]
6. Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors.
Gröne EF; Abboud HE; Höhne M; Walli AK; Gröne HJ; Stüker D; Robenek H; Wieland E; Seidel D
Am J Physiol; 1992 Oct; 263(4 Pt 2):F686-96. PubMed ID: 1329557
[TBL] [Abstract][Full Text] [Related]
7. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins.
Mondorf UF; Piiper A; Herrero M; Olbrich HG; Bender M; Gross W; Scheuermann E; Geiger H
Kidney Int; 1999 Apr; 55(4):1359-66. PubMed ID: 10201000
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A.
Ha H; Roh DD; Kirschenbaum MA; Kamanna VS
J Lab Clin Med; 1998 May; 131(5):456-65. PubMed ID: 9605111
[TBL] [Abstract][Full Text] [Related]
10. Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins.
Roh DD; Kamanna VS; Kirschenbaum MA
Am J Nephrol; 1998; 18(4):344-50. PubMed ID: 9653842
[TBL] [Abstract][Full Text] [Related]
11. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells.
Ruan XZ; Varghese Z; Fernando R; Moorhead JF
Nephrol Dial Transplant; 1998 Jun; 13(6):1391-7. PubMed ID: 9641167
[TBL] [Abstract][Full Text] [Related]
12. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
13. Interactions of low density lipoprotein with rat mesangial cells.
Wasserman J; Santiago A; Rifici V; Holthofer H; Scharschmidt L; Epstein M; Schlondorff D
Kidney Int; 1989 May; 35(5):1168-74. PubMed ID: 2770101
[TBL] [Abstract][Full Text] [Related]
14. [Atherogenic lipoprotein(a) as a progression factor in glomerular diseases: studies in cultured rat mesangial cells].
Greiber S; Gutenkunst M; Wanner C
Immun Infekt; 1995 Apr; 23(2):50-2. PubMed ID: 7744426
[TBL] [Abstract][Full Text] [Related]
15. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis.
Sharma P; Reddy K; Franki N; Sanwal V; Sankaran R; Ahuja TS; Gibbons N; Mattana J; Singhal PC
Kidney Int; 1996 Nov; 50(5):1604-11. PubMed ID: 8914027
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipoproteins on cultured human mesangial cells.
Nishida Y; Yorioka N; Oda H; Yamakido M
Am J Kidney Dis; 1997 Jun; 29(6):919-30. PubMed ID: 9186079
[TBL] [Abstract][Full Text] [Related]
18. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
[TBL] [Abstract][Full Text] [Related]
19. Interactions of LDL and modified LDL with mesangial cells and matrix.
Gupta S; Rifici V; Crowley S; Brownlee M; Shan Z; Schlondorff D
Kidney Int; 1992 May; 41(5):1161-9. PubMed ID: 1614032
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)--but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)]--in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptor.
Bartens W; Krämer-Guth A; Wanner C
Metabolism; 1997 Jul; 46(7):726-9. PubMed ID: 9225822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
